Cargando…

SGLT2 inhibitors: An answer to diabetes or a question to its complications?

Detalles Bibliográficos
Autores principales: Priya, Kumar, Ayush, Khatri, Govinda, Hasan, Mohammad Mehedi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9213700/
https://www.ncbi.nlm.nih.gov/pubmed/35757315
http://dx.doi.org/10.1016/j.amsu.2022.103992
_version_ 1784730893983678464
author Priya
Kumar, Ayush
Khatri, Govinda
Hasan, Mohammad Mehedi
author_facet Priya
Kumar, Ayush
Khatri, Govinda
Hasan, Mohammad Mehedi
author_sort Priya
collection PubMed
description
format Online
Article
Text
id pubmed-9213700
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-92137002022-06-23 SGLT2 inhibitors: An answer to diabetes or a question to its complications? Priya Kumar, Ayush Khatri, Govinda Hasan, Mohammad Mehedi Ann Med Surg (Lond) Correspondence Elsevier 2022-06-13 /pmc/articles/PMC9213700/ /pubmed/35757315 http://dx.doi.org/10.1016/j.amsu.2022.103992 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Correspondence
Priya
Kumar, Ayush
Khatri, Govinda
Hasan, Mohammad Mehedi
SGLT2 inhibitors: An answer to diabetes or a question to its complications?
title SGLT2 inhibitors: An answer to diabetes or a question to its complications?
title_full SGLT2 inhibitors: An answer to diabetes or a question to its complications?
title_fullStr SGLT2 inhibitors: An answer to diabetes or a question to its complications?
title_full_unstemmed SGLT2 inhibitors: An answer to diabetes or a question to its complications?
title_short SGLT2 inhibitors: An answer to diabetes or a question to its complications?
title_sort sglt2 inhibitors: an answer to diabetes or a question to its complications?
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9213700/
https://www.ncbi.nlm.nih.gov/pubmed/35757315
http://dx.doi.org/10.1016/j.amsu.2022.103992
work_keys_str_mv AT priya sglt2inhibitorsananswertodiabetesoraquestiontoitscomplications
AT kumarayush sglt2inhibitorsananswertodiabetesoraquestiontoitscomplications
AT khatrigovinda sglt2inhibitorsananswertodiabetesoraquestiontoitscomplications
AT hasanmohammadmehedi sglt2inhibitorsananswertodiabetesoraquestiontoitscomplications